BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 3185634)

  • 1. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases.
    Stampfer MJ; Willett WC; Colditz GA; Speizer FE; Hennekens CH
    N Engl J Med; 1988 Nov; 319(20):1313-7. PubMed ID: 3185634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke in users of low-dose oral contraceptives.
    Petitti DB; Sidney S; Bernstein A; Wolf S; Quesenberry C; Ziel HK
    N Engl J Med; 1996 Jul; 335(1):8-15. PubMed ID: 8637557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term study of mortality in men who have undergone vasectomy.
    Giovannucci E; Tosteson TD; Speizer FE; Vessey MP; Colditz GA
    N Engl J Med; 1992 May; 326(21):1392-8. PubMed ID: 1569975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral contraceptives and cardiovascular diseases morbidity].
    Lara Ricalde R; Aznar Ramos R
    Ginecol Obstet Mex; 1986 May; 54():119-25. PubMed ID: 3732840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of hormonal contraceptives for coronary heart disease].
    Gohlke-Bärwolf C
    Herz; 1987 Aug; 12(4):263-75. PubMed ID: 3308662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects.
    Grimes DA
    Int J Fertil; 1989; 34 Suppl():27-33. PubMed ID: 2576254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
    Contracept Rep; 1995 May; 6(2):4-9, 14. PubMed ID: 12319497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.
    Manson JE; Colditz GA; Stampfer MJ; Willett WC; Krolewski AS; Rosner B; Arky RA; Speizer FE; Hennekens CH
    Arch Intern Med; 1991 Jun; 151(6):1141-7. PubMed ID: 2043016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives: the risks in perspective.
    Kanell RG
    Nurse Pract; 1984 Sep; 9(9):25-6, 28-9, 62. PubMed ID: 6493646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking and risk of stroke in middle-aged women.
    Colditz GA; Bonita R; Stampfer MJ; Willett WC; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1988 Apr; 318(15):937-41. PubMed ID: 3352685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the health risks and benefits of contraceptive choices.
    Kost K; Forrest JD; Harlap S
    Fam Plann Perspect; 1991; 23(2):54-61. PubMed ID: 2060612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term health risks and benefits of oral contraceptive use.
    Peterson HB; Lee NC
    Obstet Gynecol Clin North Am; 1990 Dec; 17(4):775-88. PubMed ID: 2092241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.